| Literature DB >> 21184204 |
Uygar C Yuksel1, Samir R Kapadia, E Murat Tuzcu.
Abstract
Percutaneous heart valve therapies are rapidly changing our approach to valvular heart diseases. Currently, mitral valve surgery is the treatment of choice for patients suffering from severe symptomatic mitral regurgitation. However surgery, because of its inherent risks, is not applicable to all patients, particularly for the elderly with comorbidities. Catheter-based mitral repair systems offer a new option to those high-risk patients. The edge-to-edge repair using the MitraClip device (Evalve, Menlo Park, CA), simulating the surgical Alfieri stitch via percutaneous approach proved to be a safe and feasible technique. This article discusses the currently available data for the MitraClip transcatheter mitral repair system.Entities:
Mesh:
Year: 2011 PMID: 21184204 DOI: 10.1007/s11886-010-0158-x
Source DB: PubMed Journal: Curr Cardiol Rep ISSN: 1523-3782 Impact factor: 2.931